These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2008-006439-12 Momento Estratégico para el Inicio de la Terapia Antiretroviral Strategic Timing of AntiRetroviral Treatment (START) 2022-03-31 bad-data
Reported results 2014-004271-22 Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006: FLU-IVIG) 2018-07-02 due-trials
Reported results 2020-001052-18 A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for European Unio... 2020-09-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2020-002542-16 An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Tr... 2021-05-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2020-003278-37 A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients with COVID-19 2023-07-14 bad-data
Other 2021-001663-24 An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Tr... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2021-003386-35 SARS-CoV-2 vaccination strategies in previous hospitalised and recovered COVID-19 patients 2022-12-21 bad-data